Prevalence of factor V Leiden in a population of patients with congenital heart disease

Canadian Journal of Anaesthesia

Volumn 45, Issue 12, 1998, Pages 1176-1180

  Ong, Biauw Chi ^a   Zimmerman, A Andrew ^a   Zappulla, David C ^a   Neufeld, Ellis J ^a   Burrows, Frederick A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5A; DNA; PROTEIN C;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THROMBOSIS;

EID: 0032452262     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012459     Document Type: Article

References (18)

1. Dobell ARC, Trusler GA, Smallhorn JF, Williams WG. Atrial thrombi after the Fontan operation. Ann Thorac Surg 1986; 42: 664-7.
2. Okita T, Miki S, Kusuhara K, et al. Massive systemic venous thrombosis after Fontan operation: report of a case. Thorac Cardiovasc Surg 1988; 36: 234-6.
3. Franklin WH, Norwood WI. Management of complications related to the Fontan procedure. In: Waldhausen JA, Orringer MB (Eds.). Complications in Cardiothoracic Surgery. St. Louis: Mosby Year Book, 1991: 202-11.
4. Jahangiri M, Shore D, Kakkar V, Lincoln C, Shinebourne E. Coagulation factor abnormalities after the Fontan procedure and its modification. J Thorac Cardiovasc Surg 1997; 113: 989-93.
5. Samaha M, Trossaert M, Conard J, Horellou MH, Elalamy I, Samama MM. Prevalence and patient profile in activated protein C resistance. Am J Clin Pathol 1995; 104: 450-4.
6. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JF, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-6.
7. Nuss R, Hays T, Manco-Johnson M. Childhood thrombosis. Pediatrics 1995; 96: 291-4.
8. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci (USA) 1993; 90: 1004-8.
9. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
10. Svensson PJ, Dablbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22.
11. Glauser TA, Rorke LB, Weinberg PM, Clancy RR. Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics 1990; 85: 984-90.
12. Yandava CN, Zappulla DC, Korf BR, Neufeld EJ. ARMS test for diagnosis of factor V Leiden mutation, a common of inherited thrombotic tendency. J Clin Lab Anal 1996; 10: 414-7.
13. Tait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93.
14. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991; 77: 930-6.
15. Turner-Gomes SO, Mitchell L, Williams WG, Andrew M. Thrombin regulation in congenital heart disease after cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1994; 107: 562-8.
16. Knöbl PN, Zilla P, Fasol R, Müller MM, Vukovich TC. The protein C system in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 94: 600-5.
17. Ankola P, Nardi M, Karpatkin M. Functional activity of protein C in newborn infants. A report of a study and a review of the literature. Am J Pediatr Hematol Oncol 1992; 14: 140-3.
18. Boldt J, Knothe C, Schindler E, Welters A, Dapper FF, Hempelmann G. Thrombomodulin in pediatric cardiac surgery. Ann Thorac Surg 1994; 57: 1584-9.